BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 33822324)

  • 1. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection.
    Welcome MO; Mastorakis NE
    Inflammopharmacology; 2021 Aug; 29(4):939-963. PubMed ID: 33822324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanisms of Proteins - Targets for SARS-CoV-2 (Review).
    Morgun AV; Salmin VV; Boytsova EB; Lopatina OL; Salmina AB
    Sovrem Tekhnologii Med; 2021; 12(6):98-108. PubMed ID: 34796023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
    Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
    Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms.
    Huang X; Hussain B; Chang J
    CNS Neurosci Ther; 2021 Jan; 27(1):36-47. PubMed ID: 33381913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes.
    Lee CY; Huang CH; Rastegari E; Rengganaten V; Liu PC; Tsai PH; Chin YF; Wu JR; Chiou SH; Teng YC; Lee CW; Liang Y; Chen AY; Hsu SC; Hung YJ; Sun JR; Chien CS; Chien Y
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.
    Patra T; Meyer K; Geerling L; Isbell TS; Hoft DF; Brien J; Pinto AK; Ray RB; Ray R
    PLoS Pathog; 2020 Dec; 16(12):e1009128. PubMed ID: 33284859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 journey to the brain with a focus on potential role of docosahexaenoic acid bioactive lipid mediators.
    Hachem M
    Biochimie; 2021 May; 184():95-103. PubMed ID: 33639198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
    Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the mechanisms of blood-brain barrier disruption during COVID-19 infection.
    Jamil Al-Obaidi MM; Desa MNM
    J Neurosci Res; 2023 Nov; 101(11):1687-1698. PubMed ID: 37462109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
    Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
    J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of coronavirus infectious disease 2019-related neurologic diseases.
    Klein RS
    Curr Opin Neurol; 2022 Jun; 35(3):392-398. PubMed ID: 35283461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells.
    Kim ES; Jeon MT; Kim KS; Lee S; Kim S; Kim DG
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.
    Cardinale V; Capurso G; Ianiro G; Gasbarrini A; Arcidiacono PG; Alvaro D
    Dig Liver Dis; 2020 Dec; 52(12):1383-1389. PubMed ID: 33023827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated ethanol exposure and withdrawal alters angiotensin-converting enzyme 2 expression in discrete brain regions: Implications for SARS-CoV-2 neuroinvasion.
    Balasubramanian N; James TD; Selvakumar GP; Reinhardt J; Marcinkiewcz CA
    Alcohol Clin Exp Res (Hoboken); 2023 Feb; 47(2):219-239. PubMed ID: 36529893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis.
    Gugliandolo A; Chiricosta L; Calcaterra V; Biasin M; Cappelletti G; Carelli S; Zuccotti G; Avanzini MA; Bramanti P; Pelizzo G; Mazzon E
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
    Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
    Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
    Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
    Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
    Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.